| Sažetak | Uvod: Hipertenzija je danas jedan od vodećih uzroka smrti. Smatra se kako je kvaliteta života kod pacijenata s hipertenzijom narušena.
Cilj: Procijeniti kvalitetu života pacijenata oboljelih od hipertenzije s obzirom na samoučinkovitost pridržavanja uzimanja antihipertenzivne terapije
Ispitanici i metode: Istraživanje je obuhvatilo 254 ispitanika kojima je dijagnosticirana hipertenzija a liječe se u ordinaciji opće medicine Ivanke Dodig Bravić, dr. med. spec. obit. med., Istraživanje se provelo anonimnom anketom u papirnatom obliku, obuhvaćajući sociodemografski upitnik, hrvatsku verziju skraćenog MINICHAL upitnika i hrvatsku verziju MASES ljestvice u razdoblju od prosinca 2022. do veljače 2023.
Rezultati: Srednja vrijednost trajanja hipertenzije kod ispitanika je 12 godina s interkvartilnim rasponom od 14 godina (IQR= 14,00-20,00 godina). Najveći broj ispitanika ima hipertenziju stupnja I (n=108). Za 30,75 puta je veći broj ispitanika koji smatraju kako je njihova hipertenzija pod kontrolom otkad piju lijekove te je ispitivanjem utvrđeno kako je riječ o statistički značajnoj većini (χ2=223,01; P<0,001). Značajni utjecaj na kvalitetu života ima konzumacija benzodiazepina; ispitanici koji ne konzumiraju benzodiazepine imaju bolju kvalitetu života od ispitanika koji ih ne konzumiraju (p<0,0001). Na samoučinkovitost uzimanja antihipertenzivne terapije najveću utjecaj ima zaposlenje; nezaposleni ispitanici pokazali su veću samoučinkovitost uzimanja lijekova od onih koji su zaposleni (p<0,0001). ). Ispitanici koji imaju hobi imaju za 0,11 bodova veću vrijednost na MASES skali te je ispitivanjem utvrđena prisutnost statistički značajne razlike (U=2,98; P=0,017), a ustanovljeno je kako starenjem pacijenata je prisutna tendencija rasta vrijednosti na MASES ljestvici (rho=0,32; P<0,001).
Zaključak: Samoučinkovitost uzimanja antihipertenzivne terapije nije povezana s kvalitetom života (p=0,228). Međutim, zaposleni pacijenti imaju bolju kvalitetu života (p=0,036), kao i pacijenti koji ne puše (p=0,035) i koji ne konzumiraju benzodiazepine (p<0,001). Većina ispitanika se pridržava uzimanja terapije, ali kod nekih skupina postoji veći statistički značaj. Tako se nezaposleni pacijenti više pridržavaju uzimanja terapije u odnosu na nezaposlene (p<0,001) i ispitanici s hobije također se više pridržavaju uzimanja terapije od onih koji nemaju hobi (p<0,001). Dob ne utječe na kvalitetu života, ali utječe na uzimanje antihipertenzivne terapije. Time, pacijenti staranjem imaju sve pozitivniju samoučinkovitost uzimanja antihipertenziva (p<0,0001). |
| Sažetak (engleski) | Introduction: Hypertension is one of the leading causes of death today. It is considered that the quality of life in patients with hypertension is impaired.
Aim: To assess the quality of life of patients suffering from hypertension with regard to the self-efficacy of adherence to antihypertensive therapy.
Subject and methods: The research included 254 subjects who were diagnosed with hypertension and were treated in the general medicine office of Ivanka Dodig Bravić, MD. spec fam. med., The research was conducted with an anonymous survey in paper form, including a sociodemographic questionnaire, the Croatian version of the abbreviated MINICHAL questionnaire and the Croatian version of the MASES scale in the period from December 2022 to February 2023.
Results: The mean duration of hypertension in the subjects was 12 years with an interquartile range of 14 years (IQR= 14.00-20.00 years). The largest number of respondents have hypertension of the first degree (n=108). The number of respondents who believe that their hypertension is under control since taking medication is 30.75 times higher, and the survey determined that this is a statistically significant majority (χ2=223.01; P<0.001). The consumption of benzodiazepines has a significant impact on the quality of life; subjects who do not consume benzodiazepines have a better quality of life than subjects who do not consume them (p<0.0001). Employment has the greatest influence on the self-efficacy of taking antihypertensive therapy; unemployed respondents showed higher self-efficacy in taking medication than those who were employed (p<0.0001). ). Respondents who have a hobby have a 0.11 point higher value on the MASES scale, and the examination established the presence of a statistically significant difference (U=2.98; P=0.017), and it was established that as the patients get older, there is a tendency for the value on the MASES scale to increase ( rho=0.32; P<0.001).
Conclusion: Self-efficacy of taking antihypertensive therapy is not related to quality of life (p=0.228). However, employed patients have a better quality of life (p=0.036), as do patients who do not smoke (p=0.035) and do not consume benzodiazepines (p<0.001). The majority of subjects adhere to therapy, but in some groups there is a greater statistical significance. Thus, unemployed patients adhere more to taking therapy compared to unemployed patients (p<0.001) and subjects with a hobby also adhere more to taking therapy than those who do not have a hobby (p<0.001). Age does not affect the quality of life, but it does affect the taking of antihypertensive therapy. Thus, as patients get older, they have an increasingly positive self-efficacy in taking antihypertensive drugs (p<0.0001). |
